We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current CGS market cap is 208.15M. The company's latest EPS is USD 0.0314 and P/E is 38.22.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 22.84M | 35.15M | 44.98M | 40.6M | 44.33M |
| Operating Income | -2.77M | 6.29M | 10.86M | 2.4M | 7.08M |
| Net Income | -1.96M | 5.23M | 7.52M | 3.57M | 5.45M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 31.92M | 51.38M | 58.45M | 54.07M | 57.84M |
| Total Liabilities | 16.43M | 29.6M | 25.53M | 16.38M | 16.92M |
| Total Equity | 15.49M | 21.78M | 32.92M | 37.69M | 40.92M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 730k | 16.11M | 9.73M | 654k | 5.79M |
| Investing | -2.83M | -2.62M | -3.53M | -1.68M | -1.12M |
| Financing | 9.21M | -184k | 760k | -895k | -3.22M |
| Market Cap | 208.15M |
| Price to Earnings Ratio | 38.22 |
| Price to Sales Ratio | 4.69 |
| Price to Cash Ratio | 6.91 |
| Price to Book Ratio | 5.09 |
| Dividend Yield | - |
| Shares Outstanding | 173.46M |
| Average Volume (1 week) | 31.49k |
| Average Volume (1 Month) | 62.53k |
| 52 Week Change | 3.45% |
| 52 Week High | 1.44 |
| 52 Week Low | 0.795 |
| Spread (Intraday) | 0.05 (4.17%) |
| Company Name | Cogstate Ltd |
| Address |
level 2, 255 bourke street, 21 victoria street melbourne, victoria 3000 |
| Website | https://www.cogstate.com |
| Industry | health & allied services,nec (8099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
